Shares of Neovasc, Inc. (NASDAQ:NVCN) Decline as Company Provides Update on its Tiara™ Mitral Valve Clinical Program

Shares of Neovasc, Inc. (NASDAQ:NVCN) Decline as Company Provides Update on its Tiara™ Mitral Valve Clinical Program

Specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace, Neovasc, Inc. (NASDAQ:NVCN), provides investors with an update on its newest program. VANCOUVER, Dec. 6, 2016 /PRNewswire/ – Neovasc Inc. (“Neovasc” or the “Company”) (NVCN) (NVC.TO) today provided an update on the clinical experience with its Tiara™ transcatheter mitral valve.  Tiara™ is a novel transcatheter device designed to treat mitral regurgitation (MR), a condition […]

Read More ˃
Applied DNA Sciences, Inc. (NASDAQ:APDN) Continues Its Successful Program Protecting Automobiles in Scandinavia, Hopeful that Investors are Taking Note

Applied DNA Sciences, Inc. (NASDAQ:APDN) Continues Its Successful Program Protecting Automobiles in Scandinavia, Hopeful that Investors are Taking Note

Provider of DNA-based supply-chain, anti-counterfeiting and anti-theft technology, Applied DNA Sciences, Inc. (NASDAQ:APDN), continues its mission to protect Scandanavian automobiles. STONY BROOK, NY–(Marketwired – December 07, 2016) – Applied DNA Sciences, Inc. (APDN) (“Applied DNA” or the “Company”), a provider of DNA-based supply-chain, anti-counterfeiting and anti-theft technology, product genotyping and product authentication solutions, is continuing its quest to protect automobiles in Scandinavia. During fiscal 2016, Applied DNA realized revenues of […]

Read More ˃
Shares of Cumulus Media, Inc. (NASDAQ:CMLS) Jump Upon Announcement of  Entry into Refinancing Support Agreement with Holders

Shares of Cumulus Media, Inc. (NASDAQ:CMLS) Jump Upon Announcement of Entry into Refinancing Support Agreement with Holders

Leader in the radio broadcast industry, Cumulus Media, Inc. (NASDAQ:CMLS), announces that it has entered into a refinancing support agreement with their holders. ATLANTA, Dec. 07, 2016 (GLOBE NEWSWIRE) — Cumulus Media Inc. (CMLS) (the “Company”) today announced that it has entered into a refinancing support agreement (the “Refinancing Support Agreement”) with the holders of approximately $349.7 million, or 57.3%, of the aggregate principal amount of the outstanding 7.75% Senior […]

Read More ˃
OHA Investment, Corp. (NASDAQ:OHAI) Announces Form 8-K Filing as Share Price Plummets

OHA Investment, Corp. (NASDAQ:OHAI) Announces Form 8-K Filing as Share Price Plummets

Specialty finance company designed to provide its investors with current income and capital appreciation, OHA Investment, Corp. (NASDAQ:OHAI), announces that it has filed a current report on Form 8-K, updating shareholders. NEW YORK, Dec. 06, 2016 (GLOBE NEWSWIRE) — OHA Investment Corporation (OHAI) (the “Company”) today announced that it has filed a current report on Form 8-K to provide shareholders with updated information regarding two of the Company’s legacy portfolio […]

Read More ˃
Viking Therapeutics, Inc. (NASDAQ:VKTX) Receives Orphan Drug Designation for VK0214, How Will Investors React?

Viking Therapeutics, Inc. (NASDAQ:VKTX) Receives Orphan Drug Designation for VK0214, How Will Investors React?

Clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, Viking Therapeutics, Inc. (NASDAQ:VKTX), announces that the U.S. FDA has granted the orphan drug designation to their VK0214. SAN DIEGO, Dec. 6, 2016 /PRNewswire/ — Viking Therapeutics, Inc. (“Viking”) (VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that the U.S. Food and Drug Administration […]

Read More ˃
Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) Announces Leadership Change, Share Price Explodes Upon News

Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) Announces Leadership Change, Share Price Explodes Upon News

Biopharmaceutical company focused on developing and commercializing products to treat serious and life-threatening diseases, including exocrine pancreatic insufficiency due to cystic fibrosis, IgA nephropathy, lupus, and lupus with glomerulonephritis, Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH), announce a series of changes at the top of its executive team. HAYWARD, Calif., Dec. 06, 2016 (GLOBE NEWSWIRE) — Today the Anthera Pharmaceuticals Inc. (ANTH) Board of Directors announced J. Craig Thompson has been promoted to […]

Read More ˃
Atossa Genetics, Inc. (NASDAQ:ATOS) Will Present at the 9th Annual LD Micro Main Event Conference on December 7, 2016, Awaits Market Response to News

Atossa Genetics, Inc. (NASDAQ:ATOS) Will Present at the 9th Annual LD Micro Main Event Conference on December 7, 2016, Awaits Market Response to News

Clinical-stage pharmaceutical company developing novel therapeutics and delivery methods to treat breast cancer and other breast conditions, Atossa Genetics, Inc. (NASDAQ:ATOS), announces it will present at the Micro Main Event Conference. SEATTLE, WA–(Marketwired – Dec 1, 2016) – Atossa Genetics, Inc. ( NASDAQ : ATOS ) announced today that Kyle Guse, CFO and General Counsel, will be a featured presenter at the 9th annual LD Micro Main Event Conference on […]

Read More ˃
Carl Icahn Adds 15% Stake in Enzon Pharmaceuticals, Inc. (OTCMKTS:ENZN), How Will Other Investors React?

Carl Icahn Adds 15% Stake in Enzon Pharmaceuticals, Inc. (OTCMKTS:ENZN), How Will Other Investors React?

Former research stage biopharmaceutical company and now surviving off roalyty streams, Enzon Pharmaceuticals, Inc. (OTCMKTS:ENZN), announces that Carl Icahn has taken an additional 15% position in the company. After selling out in the second quarter, Carl Icahn (Trades, Portfolio) acquired an even larger position in Enzon Pharmaceuticals (ENZN) on Nov. 28. He bought 6,598,886 shares for an average cost of 41 cents per share. This represents nearly 15% of the […]

Read More ˃
How Will the Market React to Porter Bancorp, Inc. (NASDAQ:PBIB) Announcing Appellate Court Affirms Ruling?

How Will the Market React to Porter Bancorp, Inc. (NASDAQ:PBIB) Announcing Appellate Court Affirms Ruling?

Louisville, Kentucky-based bank holding company which operates banking centers in 12 counties through its wholly-owned subsidiary PBI Bank, Porter Bancorp, Inc. (NASDAQ:PBIB), announces that the Kentucky Court of Appeals has ruled against them. Porter Bancorp, Inc. (PBIB), parent company of PBI Bank, today announced that the Kentucky Court of Appeals ruled against the Bank in a decision with a partial dissenting opinion in the PBI Bank, Inc. v. Signature Point […]

Read More ˃
Military Youth to Unveil Mural in Partnership with the Sears Canada, Inc. (NASDAQ:SRSC) Operation Wish Program, How Will the Market Respond?

Military Youth to Unveil Mural in Partnership with the Sears Canada, Inc. (NASDAQ:SRSC) Operation Wish Program, How Will the Market Respond?

The #1 retailer of major appliances in Canada with all top ten brands, Sears Canada, Inc. (NASDAQ:SRSC), announces partnership with the Winnipeg Military Family Resource Centre. WINNIPEG , Dec. 1, 2016 /CNW/ – Santa Claus is in town to make an early delivery of gifts to the Winnipeg Military Family Resource Centre’s Doncaster street youth facility as six military family youth officially unveil their art creation to their families and […]

Read More ˃
CTI BioPharma, Corp. (NASDAQ:CTIC) Presents at EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium as Share Price Advances

CTI BioPharma, Corp. (NASDAQ:CTIC) Presents at EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium as Share Price Advances

Biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies covering a spectrum of blood-related cancers that offer a unique benefit to patients and healthcare providers, CTI BioPharma, Corp. (NASDAQ:CTIC) announced the results of a translational pharmacology study. SEATTLE, Dec. 1, 2016 /PRNewswire/ — CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) today announced the results of a translational pharmacology study comparing biomarker activity profiles for […]

Read More ˃
Neovasc, Inc. (NASDAQ:NVCN) Explodes Upon Announcement of Agreement with Boston Scientific

Neovasc, Inc. (NASDAQ:NVCN) Explodes Upon Announcement of Agreement with Boston Scientific

Specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace, Neovasc, Inc. (NASDAQ:NVCN), announces purchase agreement with longtime customer, Boston Scientific. VANCOUVER , Dec. 2, 2016 /CNW/ – Neovasc Inc. (“Neovasc” or the “Company”) (NVCN) (NVC.TO) today announced that Boston Scientific Corporation (BSX), a global medical technology leader, has agreed to acquire Neovasc’s tissue processing technology and facility for approximately US$67,909,800 . Concurrently, Boston […]

Read More ˃
Cellectar Biosciences, Inc. (NASDAQ:CLRB) Announces Mixed Results From the First Two Cohorts of Its CLR 131 Phase 1 Trial as Shares Decline

Cellectar Biosciences, Inc. (NASDAQ:CLRB) Announces Mixed Results From the First Two Cohorts of Its CLR 131 Phase 1 Trial as Shares Decline

Oncology-focused, clinical stage biotechnology company, Cellectar Biosciences, Inc. (NASDAQ:CLRB), announces results from the company’s Phase 1 clinical study of CLR 131. MADISON, Wis., Dec. 01, 2016 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (CLRB) (the “company”), an oncology-focused, clinical stage biotechnology company, today provides a data update on the first two cohorts of the company’s Phase I clinical study of CLR 131 in patients with relapsed or refractory multiple myeloma. The […]

Read More ˃
ENGlobal, Corp. (NASDAQ:ENG) Announces Process Analytical Award Valued at $7 million, Awaits Market Response

ENGlobal, Corp. (NASDAQ:ENG) Announces Process Analytical Award Valued at $7 million, Awaits Market Response

Leading provider of engineering and automation services, ENGlobal, Corp. (NASDAQ:ENG), announces a new project award valued at around $7 million. HOUSTON, TX–(Marketwired – Nov 29, 2016) – ENGlobal ( NASDAQ : ENG ), a leading provider of engineering and automation services, today announced a new project award valued at approximately $7 million. ENGlobal’s Automation business segment has been selected as the supplier of Analytical Process Control Equipment for a major […]

Read More ˃
CounterPath, Corp. (NASDAQ:CPAH) Selected By Leading Brazilian Solution Provider for Major Government and Finance Sector Projects, How Will Investors React to the News?

CounterPath, Corp. (NASDAQ:CPAH) Selected By Leading Brazilian Solution Provider for Major Government and Finance Sector Projects, How Will Investors React to the News?

Global provider of award-winning, over-the-top Unified Communications solutions for enterprises and carriers, CounterPath, Corp. (NASDAQ:CPAH), announces new OEM agreement with Digivox. VANCOUVER, BRITISH COLUMBIA–(Marketwired – Dec 1, 2016) – CounterPath Corporation (CPAH)(PATH.TO), a global provider of award-winning, over-the-top (OTT) Unified Communications (UC) solutions for enterprises and carriers, today announced a new OEM agreement with Digivox, a leading Brazilian solution provider for enterprises. The agreement has already enabled Digivox to convert […]

Read More ˃
Insignia Systems, Inc. (NASDAQ:ISIG) Announces Special Cash Dividend, How Will This News Affect the Share Price?

Insignia Systems, Inc. (NASDAQ:ISIG) Announces Special Cash Dividend, How Will This News Affect the Share Price?

Developer and marketer of innovative in-store products, programs and services that help consumer goods manufacturers and retail partners drive sales at the point of purchase, Insignia Systems, Inc. (NASDAQ:ISIG), announces new special cash dividend. MINNEAPOLIS, MN / ACCESSWIRE / November 28, 2016 / Insignia Systems, Inc. (ISIG) (“Insignia”) announced today that its Board of Directors has declared a special cash dividend of $0.70 per share, payable on January 6, 2017 […]

Read More ˃
Christopher & Banks, Corp. (NYSE:CBK) Reports Third Quarter Fiscal 2016 Financial Results, How Will the Market Respond?

Christopher & Banks, Corp. (NYSE:CBK) Reports Third Quarter Fiscal 2016 Financial Results, How Will the Market Respond?

Specialty women’s apparel retailer, Christopher & Banks, Corp. (NYSE:CBK), releases Q3, 2016 financials. MINNEAPOLIS–(BUSINESS WIRE)– Christopher & Banks Corporation (CBK), a specialty women’s apparel retailer, today reported results for the third quarter ended October 29, 2016. Results for the Third Quarter Ended October 29, 2016     Net sales totaled $106.7 million, an increase of 2.9%, while operating on average 506 stores, compared to $103.6 million in net sales for the […]

Read More ˃
Central Federal, Corp. (NASDAQ:CFBK) Announces Conversion Of CFBank To A National Bank Charter, How Will This Affect the Share Price?

Central Federal, Corp. (NASDAQ:CFBK) Announces Conversion Of CFBank To A National Bank Charter, How Will This Affect the Share Price?

Holding company for CFBank, a federally chartered financial institution formed in 1892, Central Federal, Corp. (NASDAQ:CFBK), announces that CFBank will convert to a national bank charter. WORTHINGTON, Ohio, Nov. 28, 2016 /PRNewswire/ — Central Federal Corporation (CFBK) (the “Company”) announced that the Company and its wholly-owned banking subsidiary, CFBank, have received the necessary regulatory approvals for CFBank to convert from a federal savings bank charter to a national bank charter […]

Read More ˃
DOE Awards $4.5 Million to Superconductor Technologies, Inc. (NASDAQ:SCON) Awarded $4.5 Million by DOE as Stock Skyrockets

DOE Awards $4.5 Million to Superconductor Technologies, Inc. (NASDAQ:SCON) Awarded $4.5 Million by DOE as Stock Skyrockets

Global leader in superconducting innovation, Superconductor Technologies, Inc. (NASDAQ:SCON), announces it has received a $4.5 million program award provided by the U.S. Department of Energy. AUSTIN, Texas, Nov. 29, 2016 (GLOBE NEWSWIRE) — Superconductor Technologies Inc. (STI) (SCON) has been selected as prime recipient of the $4.5 million program award provided by the U.S. Department of Energy’s (DOE) Office of Energy Efficiency and Renewable Energy (EERE), on behalf of the […]

Read More ˃
Royale Energy, Inc. (OTCMKTS:ROYL) on the Rise Following Definitive Merger Agreement With Matrix Oil Management, How Long Will the Boost Last?

Royale Energy, Inc. (OTCMKTS:ROYL) on the Rise Following Definitive Merger Agreement With Matrix Oil Management, How Long Will the Boost Last?

Independent exploration and production company focused on the acquisition, development, and marketing of natural gas, Royale Energy, Inc. (OTCMKTS:ROYL), announces merger agreement with Matrix Oil Management. SAN DIEGO, Nov. 30, 2016 (GLOBE NEWSWIRE) — Royale Energy, Inc. (ROYL) (“Royale” or the “Company”) and privately held Matrix Oil Management Corporation (“Matrix”) jointly announced today that they have entered into a definitive agreement to merge whereby Royale will acquire substantially all of […]

Read More ˃